Twist Bioscience Corporation Goodwill, Acquired During Period
Twist Bioscience Corporation (TWST) reported Goodwill, Acquired During Period of $0 for the 12-month period ending 2023-09-30, per its 10-K filed 2023-11-21.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2023-11-21
- Twist Bioscience Corporation goodwill, acquired during period for the quarter ending 2023-09-30 was $0.00.
- Twist Bioscience Corporation goodwill, acquired during period for the quarter ending 2023-06-30 was $0.00.
- Twist Bioscience Corporation goodwill, acquired during period for the quarter ending 2023-03-31 was $0.00.
- Twist Bioscience Corporation goodwill, acquired during period for the quarter ending 2022-12-31 was $0.00.
- Twist Bioscience Corporation goodwill, acquired during period for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Twist Bioscience Corporation goodwill, acquired during period for fiscal 2022 was $61.77M, a 186.79% increase from fiscal 2021.
- Twist Bioscience Corporation goodwill, acquired during period for fiscal 2021 was $21.54M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month | Goodwill, Acquired During Period 12 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $0.00 derived: sum of 2 quarters · filed 2023-11-21 | $0.00 derived: sum of 3 quarters · filed 2023-11-21 | $0.00 10-K · filed 2023-11-21 | |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-07 | $0.00 derived: sum of 2 quarters · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | ||
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-08 | $0.00 10-Q · filed 2023-05-08 | |||
| 2022-12-31 | $0.00 10-Q · filed 2023-02-07 | ||||
| 2022-09-30 | $61.77M 10-K · filed 2023-11-21 | ||||
| 2021-09-30 | $21.54M 10-K/A · filed 2023-06-05 | $21.30M 10-K · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |